Literature DB >> 20421892

PRMT5 regulates Golgi apparatus structure through methylation of the golgin GM130.

Zhongwei Zhou1, Xiaotian Sun, Zhenhua Zou, Litao Sun, Tao Zhang, Shaoshi Guo, Ya Wen, Lin Liu, Yi Wang, Jun Qin, Lei Li, Weimin Gong, Shilai Bao.   

Abstract

Maintenance of the Golgi apparatus (GA) structure and function depends on Golgi matrix proteins. The posttranslational modification of Golgi proteins such as phosphorylation of members of the golgin and GRASP families is important for determining Golgi architecture. Some Golgi proteins including golgin-84 are also known to be methylated, but the function of golgin methylation remains unclear. Here, we show that the protein arginine methyltransferase 5 (PRMT5) localizes to the GA and forms complexes with several components involved in GA ribbon formation and vesicle tethering. PRMT5 interacts with the golgin GM130, and depletion of PRMT5 causes defects in Golgi ribbon formation. Furthermore, PRMT5 methylates N-terminal arginines in GM130, and such arginine methylation appears critical for GA ribbon formation. Our findings reveal a molecular mechanism by which PRMT5-dependent arginine methylation of GM130 controls the maintenance of GA architecture.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20421892     DOI: 10.1038/cr.2010.56

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  33 in total

1.  Evolutionary emergence of a novel splice variant with an opposite effect on the cell cycle.

Authors:  Muhammad Sohail; Jiuyong Xie
Journal:  Mol Cell Biol       Date:  2015-04-13       Impact factor: 4.272

Review 2.  Protein arginine methylation in parasitic protozoa.

Authors:  John C Fisk; Laurie K Read
Journal:  Eukaryot Cell       Date:  2011-06-17

Review 3.  Golgi post-translational modifications and associated diseases.

Authors:  Sven Potelle; André Klein; François Foulquier
Journal:  J Inherit Metab Dis       Date:  2015-05-13       Impact factor: 4.982

4.  MCPH1 regulates the neuroprogenitor division mode by coupling the centrosomal cycle with mitotic entry through the Chk1-Cdc25 pathway.

Authors:  Ralph Gruber; Zhongwei Zhou; Mikhail Sukchev; Tjard Joerss; Pierre-Olivier Frappart; Zhao-Qi Wang
Journal:  Nat Cell Biol       Date:  2011-09-25       Impact factor: 28.824

5.  srGAP2 arginine methylation regulates cell migration and cell spreading through promoting dimerization.

Authors:  Shaoshi Guo; Shilai Bao
Journal:  J Biol Chem       Date:  2010-09-01       Impact factor: 5.157

6.  Protein arginine methyltransferase 5 is essential for growth of lung cancer cells.

Authors:  Zhongping Gu; Shen Gao; Fahao Zhang; Zhiqiang Wang; Wencai Ma; Richard E Davis; Zhengxin Wang
Journal:  Biochem J       Date:  2012-09-01       Impact factor: 3.857

7.  Overexpression of PRMT5 promotes tumor cell growth and is associated with poor disease prognosis in epithelial ovarian cancer.

Authors:  Xiangxiang Bao; Shan Zhao; Ting Liu; Yang Liu; Yueyang Liu; Xingsheng Yang
Journal:  J Histochem Cytochem       Date:  2013-01-04       Impact factor: 2.479

8.  Targeting methyltransferase PRMT5 eliminates leukemia stem cells in chronic myelogenous leukemia.

Authors:  Yanli Jin; Jingfeng Zhou; Fang Xu; Bei Jin; Lijing Cui; Yun Wang; Xin Du; Juan Li; Peng Li; Ruibao Ren; Jingxuan Pan
Journal:  J Clin Invest       Date:  2016-09-19       Impact factor: 14.808

9.  LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.

Authors:  Zahid Q Bonday; Guillermo S Cortez; Michael J Grogan; Stephen Antonysamy; Ken Weichert; Wayne P Bocchinfuso; Fengling Li; Steven Kennedy; Binghui Li; Mary M Mader; Cheryl H Arrowsmith; Peter J Brown; Mohammad S Eram; Magdalena M Szewczyk; Dalia Barsyte-Lovejoy; Masoud Vedadi; Ernesto Guccione; Robert M Campbell
Journal:  ACS Med Chem Lett       Date:  2018-04-23       Impact factor: 4.345

10.  GM130 regulates epithelial-to-mesenchymal transition and invasion of gastric cancer cells via snail.

Authors:  Jianquan Zhao; Chun Yang; Shujun Guo; Yonggang Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.